EX-10.15 19 dex1015.htm ROYALTY STREAM PURCHASE AGREEMENT ROYALTY STREAM PURCHASE AGREEMENTRoyalty Stream Purchase Agreement • May 5th, 2020 • North Carolina
This ROYALTY STREAM PURCHASE AGREEMENT (the “Agreement”) is entered into and effective as of the 7th day of September 2004 (the “Effective Date”), by and between Accentia, Inc., a Florida corporation (“Accentia”) and Pharmaceutical Product Development, Inc., a North Carolina corporation (“PPD”).
FIRST AMENDED AND RESTATED ROYALTY STREAM PURCHASE AGREEMENTRoyalty Stream Purchase Agreement • September 2nd, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • North Carolina
This FIRST AMENDED AND RESTATED ROYALTY STREAM PURCHASE AGREEMENT (the “Agreement”) is entered into and effective as of the 11th day of August, 2005 (the “Effective Date”), by and between Accentia Biopharmaceuticals, Inc., a Florida corporation (“Accentia”), and Pharmaceutical Product Development, Inc., a North Carolina corporation (“PPD”).
ROYALTY STREAM PURCHASE AGREEMENTRoyalty Stream Purchase Agreement • March 20th, 2020 • Liminal BioSciences Inc. • Pharmaceutical preparations • Ontario
This Royalty Stream Purchase Agreement (the “Agreement”) is entered into and effective as of the 30th day of April 2018 (the “Effective Date”), by and between Prometic Life Sciences Inc., Prometic Pharma SMT Limited, Prometic Biosciences Inc. and each of their Affiliates that at any time holds an interest in the Patents or licenses any rights thereunder and becomes a party hereto as provided in Section 5(a), which entities shall be set forth on Schedule “C” hereto which schedule shall be updated as applicable from time to time (collectively referred to as “Prometic”), on the first hand, and Structured Alpha LP (“SALP” or “Buyer”), on the second hand.
EXHIBIT 10.218 ROYALTY STREAM PURCHASE AGREEMENTRoyalty Stream Purchase Agreement • March 29th, 2000 • Ligand Pharmaceuticals Inc • Pharmaceutical preparations • New York
